AS
Aashit Sunil Modi
About Aashit Sunil Modi
Aashit Sunil Modi has 14 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Globalpfs Technologies Private Limited and Apexmed Impex Llp. Formerly with 2 companies, such as Roselabs Limited and Timesquare Pharmapack Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Globalpfs Technologies Private Limited
U47721GJ2026PTC173394
|
Director | 11 Feb 2026 | 2026 | Active |
Apexmed Impex Llp
ACG-3484
|
Designated Partner | 01 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Roselabs Limited
L51909GJ1995PLC024905
|
Director | 13 Aug 2012 | 1995 | Active |
Timesquare Pharmapack Private Limited
U25208GJ2013PTC076090
|
Director | 18 Jul 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aashit Sunil Modi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aashit Sunil Modi
Aashit Sunil Modi has 14 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Globalpfs Technologies Private Limited and Apexmed Impex Llp. Formerly with 2 companies, such as Roselabs Limited and Timesquare Pharmapack Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Aashit Sunil Modi is associated with 2 companies as Director and Designated Partner.
Aashit Sunil Modi has expertise in Technology, General Business.
Aashit Sunil Modi has 14 years in corporate governance.